Prognostic Significance of Macroscopic Appearance in Clear Cell Renal Cell Carcinoma and Its Metastasis-Predicting Model
Se Un Jeong
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Search for more papers by this authorJa-Min Park
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Search for more papers by this authorSu-Jin Shin
Department of Pathology, Hanyang University College of Medicine, Hanyang University Medical Center, Seoul, Korea
Search for more papers by this authorJungBok Lee
Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Search for more papers by this authorCheryn Song
Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Search for more papers by this authorHeounjeong Go
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Search for more papers by this authorNam Hoon Cho
Department of Pathology, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea
Search for more papers by this authorJae Y. Ro
Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Weill Medical College of Cornell University, Houston, Texas
Search for more papers by this authorCorresponding Author
Yong Mee Cho
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Correspondence: Prof. Yong Mee Cho, MD, PhD, Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea. Email: [email protected]
Search for more papers by this authorSe Un Jeong
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Search for more papers by this authorJa-Min Park
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Search for more papers by this authorSu-Jin Shin
Department of Pathology, Hanyang University College of Medicine, Hanyang University Medical Center, Seoul, Korea
Search for more papers by this authorJungBok Lee
Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Search for more papers by this authorCheryn Song
Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Search for more papers by this authorHeounjeong Go
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Search for more papers by this authorNam Hoon Cho
Department of Pathology, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea
Search for more papers by this authorJae Y. Ro
Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Weill Medical College of Cornell University, Houston, Texas
Search for more papers by this authorCorresponding Author
Yong Mee Cho
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Correspondence: Prof. Yong Mee Cho, MD, PhD, Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea. Email: [email protected]
Search for more papers by this authorAbstract
Prognostic significance of macroscopic appearance of clear cell renal cell carcinoma (ccRCC) has not yet been studied. This study aimed to define the prognostic significance of macroscopic appearance and to propose a prognostic model for post-operative metastasis in ccRCC. A total of 1,025 patients with ccRCC were analyzed for the development dataset. A separate cohort of 399 such patients was used as an external validation dataset. Macroscopic appearances were initially divided into four groups, but were later divided into two groups: a simple nodular group (700 cases, 68.3%) and an irregular outline group (325 cases, 32.7%). During the 66.1-month mean follow-up period, 98 patients (9.6%) developed metastasis. Univariate analysis revealed that metastasis was associated with older age, radical nephrectomy, larger tumor size, higher tumor grade and stage, and the irregular outline group. On multivariate analysis, age, tumor size, and macroscopic appearance remained as independent prognostic factors. These factors were used to build a prognostic model, which divided into three risk groups. The probabilities of 5-year metastasis-free survival in the low-, intermediate-, and high-risk groups were 98%, 83%, and 53%, respectively. The results showed prognostic significance of macroscopic appearance in ccRCC and propose a prognostic model to guide post-operative management of patients with ccRCC.
Supporting Information
Additional Supporting Information may be found in the online version of this article at the publisher's website.
Filename | Description |
---|---|
pin12606-sup-0001-SuppFigs-S1.tif40.2 MB |
Figure S1 Photographs of representative infiltrative pattern of clear cell renal cell carcinoma. (Original magnification: A, x100; B, x200) |
pin12606-sup-0002-SuppFigs-S2.tif315 KB |
Figure S2 Prognostic modeling in non-metastatic clear cell renal cell carcinoma using an external validation dataset. (a) The 5-year metastasis-free survival at of the three risk groups. (b) ROC curve of the prognostic model for 5-year metastasis-free survival. |
pin12606-sup-0003-SuppTab-S1.docx18.3 KB |
Table S1 Scoring method based on parameter estimates of Cox's proportional hazard model. Table S2 Comparison of clinicopathologic features between the developmental and external validation datasets. |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7–30.
- 2 Crispen PL, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED. Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers. Cancer 2008; 113: 450–60.
- 3 Levy DA, Slaton JW, Swanson DA, Dinney CP. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 1998; 159: 1163–7.
- 4 Moch H, Humphrey PA, Ulbright TM, Reuter VE. WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th edn. Lyon, France: IARC Press, 2016.
- 5 Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh Urology. 9th edn. Philadelphia, PA: Saunders Elsevier, 2007.
- 6 Meskawi M, Sun M, Trinh QD, et al. A review of integrated staging systems for renal cell carcinoma. Eur Urol 2012; 62: 303–14.
- 7 Hui AM, Takayama T, Sano K, et al. Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy. J Hepatol 2000; 33: 975–9.
- 8 He J, Shi J, Fu X, et al. The clinicopathologic and prognostic significance of gross classification on solitary hepatocellular carcinoma after hepatectomy. Medicine 2015; 94: e1331.
- 9 Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655–63.
- 10 Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471–4.
- 11 Eo SH, Hong SM, Cho HJ. K-adaptive partitioning for survival data: the kaps add-on package for R.arXiv:1306.4615. Ithaca, NY: arXiv, Cornell University Library, 2013.
- 12 Cook NR, Ridker PM. The use and magnitude of reclassification measures for individual predictors of global cardiovascular risk. Ann Intern Med 2009; 150: 795–802.
- 13Collaboration ERF. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012;2012: 1310–20.
- 14 Shimada M, Rikimaru T, Hamatsu T, et al. The role of macroscopic classification in nodular-type hepatocellular carcinoma. Am J Surg 2001; 182: 177–82.
- 15 Inayoshi J, Ichida T, Sugitani S, et al. Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment. J Gastroenterol Hepatol 2003; 18: 673–7.
- 16Japan LCSGo. The general rules for the clinical and pathological study of primary liver cancer. Jpn J Surg 1989; 19:98–129.
- 17 Lee WJ. Pathological findings described methods of liver cancer. In: WJ Lee, ed. The General Rules for the Study of Primary Liver Sancer. 2nd edn. Seoul, Korea: Korean Liver Cancer Association, 2004. pp. 27–38.
- 18 Arai E, Kanai Y, Ushijima S, Fujimoto H, Mukai K, Hirohashi S. Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues. Int J Cancer 2006; 119: 288–96.
- 19 Fukatsu A, Tsuzuki T, Sassa N, et al. Growth pattern, an important pathologic prognostic parameter for clear cell renal cell carcinoma. Am J Clin Pathol 2013; 140: 500–5.
- 20 Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 2008; 15: 1375–82.
- 21 Vleminckx K, Vakaet L, Jr., Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66: 107–19.
- 22 Thompson RH, Hill JR, Babayev Y, et al. Metastatic renal cell carcinoma risk according to tumor size. J Urol 2009; 182: 41–5.
- 23 Ku JH, Moon KC, Kwak C, Kim HH. Metachronous metastatic potential of small renal cell carcinoma: dependence on tumor size. Urology 2009; 74: 1271–5.
- 24 Pahernik S, Huber J, Pfitzenmaier J, Haferkamp A, Hohenfellner M. Small renal cell carcinoma: oncological outcome with tumour size. Scand J Urol Nephrol 2011; 45: 432–5.
- 25 Sorbellini M, Kattan MW, Snyder ME, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005; 173: 48–51.
- 26 Leibovich BC, Blute ML, Cheville JC, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma. Cancer 2003; 97: 1663–71.
- 27 Klatte T, Seligson DB, LaRochelle J, et al. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy. Cancer Epidemiol Biomarkers Prev 2009; 18: 894–900.